Nodify CDT
Blood autoantibody classifier that raises malignancy risk for selected pulmonary nodules.
- Developer
- Biodesix
- Intended use
- Diagnostic Aid
- Cancer scope
- Not reported
- Specimen
- Serum
- Molecular modality
- Protein
- Current version
- Nodify CDT current configuration (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.